ARROW CLINICAL TRIALS Trademark
Trademark Overview
On Tuesday, January 30, 2024, a trademark application was filed for ARROW CLINICAL TRIALS with the United States Patent and Trademark Office. The USPTO has given the ARROW CLINICAL TRIALS trademark a serial number of 98382051. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, September 3, 2024. This trademark is owned by Arrow Clinical Trials LLC. The ARROW CLINICAL TRIALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research, namely, conducting clinical trials for others
General Information
Serial Number | 98382051 |
Word Mark | ARROW CLINICAL TRIALS |
Filing Date | Tuesday, January 30, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Tuesday, September 3, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical and scientific research, namely, conducting clinical trials for others |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, January 30, 2024 |
Primary Code | 042 |
First Use Anywhere Date | Friday, September 2, 2022 |
First Use In Commerce Date | Friday, September 2, 2022 |
Trademark Owner History
Party Name | Arrow Clinical Trials LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Daytona Beach, FL 32117 |
Trademark Events
Event Date | Event Description |
Tuesday, January 30, 2024 | NEW APPLICATION ENTERED |
Wednesday, May 29, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, August 24, 2024 | ASSIGNED TO EXAMINER |
Tuesday, September 3, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, September 3, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, September 3, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |